Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» lung cancer
lung cancer
Roche's Avastin gives best lung cancer survival rate
Reuters, UK
Mon, 08/9/10 - 09:53 am
Roche
lung cancer
Avastin
Allos Therapeutics' Folotyn meets study goal
Yahoo/AP
Wed, 07/28/10 - 11:24 pm
Allos
Folotyn
lung cancer
Takeda, CanBas: Ended Joint Study On Cancer Drug
Nikkei,com, Japan
Thu, 06/17/10 - 10:12 am
Takeda
CanBas
lung cancer
Onyx, Bayer say Nexavar fails in lung cancer study
Yahoo/AP
Mon, 06/14/10 - 02:37 pm
Bayer
ONYX Pharmaceuticals
Nexavar
lung cancer
clinical trials
Abraxis' Abraxane meets cancer study goal
Yahoo/AP
Mon, 06/7/10 - 08:48 am
companies
Abraxane
lung cancer
ArQule says drug candidate could benefit subgroup of lung cancer patients
Yahoo/AP
Mon, 06/7/10 - 08:03 am
lung cancer
Arqule
Pfizer CEO: Excited About New Lung Cancer Drug
CNBC
Mon, 06/7/10 - 07:51 am
Pfizer
lung cancer
crizotinib
Jeff Kindler
Pharma CEOs
Encouraging News for Bristol-Myers
Yahoo/Zacks.com
Mon, 05/24/10 - 11:47 am
Bristol-Myers Squibb
lung cancer
ipilimumab
Did Transgene Jump the Gun With Novartis?
Seeking Alpha
Tue, 05/11/10 - 09:14 am
Novartis
vaccines
Transgene
lung cancer
Arqule Joins the Phase III Club
Seeking Alpha
Wed, 04/14/10 - 07:44 am
Arqule
Tarceva
lung cancer
clinical trials
Exelixis
Antisoma plunges as late-stage lung-cancer-drug trial halted
Marketwatch
Mon, 03/29/10 - 10:14 am
Antisoma
lung cancer
OSI reports European recommendation on Tarceva
Yahoo/AP
Fri, 03/19/10 - 10:23 am
OSI Pharmaceuticals
Europe
Tarceva
lung cancer
Novelos cancels lung-cancer drug project
Bizjournals.com
Fri, 03/19/10 - 08:59 am
Novelos Therapeutics
lung cancer
Abraxis' Abraxane meets lung cancer study goal
Yahoo/AP
Wed, 03/17/10 - 11:28 am
Abraxane
companies
lung cancer
Novelos Therapeutics Pivotal Phase 3 Lung Cancer Trial Does Not Meet the Primary Survival Endpoint
Marketwatch
Wed, 02/24/10 - 10:23 am
Novelos Therapeutics
lung cancer
Zactima’s FDA Application withdrawn (NASDAQ:AZN)
favstocks.com
Sun, 01/31/10 - 11:20 am
Zactima
AstraZeneca
non-small cell lung cancer
lung cancer
Novelos Therapeutics Reaches 725th Event in Pivotal Phase 3 Lung Cancer Trial
Trading Markets
Sat, 01/9/10 - 12:50 pm
Novelos Therapeutics
lung cancer
Pfizer Stops Cancer Trial as Survival Didn’t Improve
Bloomberg
Wed, 12/30/09 - 09:20 am
Pfizer
drug trials
lung cancer
figitumumab
Lilly to Benefit from OSI Rejection
Seeking Alpha
Thu, 12/17/09 - 04:00 pm
Eli Lilly
OSI Pharmaceuticals
Tarceva
lung cancer
Alimta
Novelos CEO: Very Bullish About Upcoming Pivotal Phase III Results
Seeking Alpha
Thu, 12/17/09 - 09:31 am
Novelos Therapeutics
clinical trials
lung cancer
Pages
« first
‹ previous
…
15
16
17
18
19
20
21
22
23
next ›
last »